サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404837

医療用サイクロトロンの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2023年～2030年

Medical Cyclotron Market Size, Share & Trends Analysis Report By Product (10-12 MeV, 16-18 MeV, 19-24 MeV, 24 MeV & Above), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 99 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
医療用サイクロトロンの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2023年～2030年
出版日: 2023年11月30日
発行: Grand View Research
ページ情報: 英文 99 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療用サイクロトロン市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医療用サイクロトロン市場規模は2030年までに4億7,790万米ドルに達し、予測期間中のCAGRは11.0%を記録する見込みです。

がんの有病率の増加と正確な診断のための核医学スキャンに対する需要の急増は、市場の成長を刺激する主な要因の一つです。これとは別に、外注の放射性トレーサーよりもコスト面で有利であること、PETやSPECTのような技術的に高度な診断装置が利用可能であることが、市場成長をエスカレートさせる極めて重要な役割を果たしています。

がんは世界の流行病となりつつあり、世界中で8人に1人が死亡しています。国際がん研究機関（IARC）によると、2012年の新規がん患者数は約1,410万人、がんによる死亡者数は820万人でした。慢性疾患の継続的な増加に伴い、2030年までに新たながん患者数は2,170万人に達し、1,300万人が死亡すると予測されています。がん患者の増加により、正確な診断の必要性が高まっており、これが医療用サイクロトロンの需要を促進すると推定されています。

診断のための核スキャンは、より少量の放射性物質を使用します。核トレーサーは、成長する腫瘍の正確な位置を見つけるのに役立ちます。テクネチウム-99m（Tc-99m）、ストロンチウム、タリウム、ガリウム、放射性ヨウ素は、腫瘍の診断や治療に使用される放射性物質の一部です。トレーサー物質の製造に粒子加速器が受け入れられるようになったことが、予測期間中の市場成長の引き金になると予測されています。

医療用サイクロトロン市場レポートハイライト

  • アジア太平洋は、核スキャン需要の急増、がん有病率の上昇、費用対効果の高い診断需要の増加により、2022年には約50.0%の主要シェアを占めました。
  • 中東・アフリカは予測期間中16.7%のCAGRで最速の成長が見込まれます。
  • サイクロトロン19～24MeVセグメントは、2023～2030年の予測期間に12.1%のCAGRで最速成長する見込み。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医療用サイクロトロン市場、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 医療用サイクロトロン市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 医療用サイクロトロン市場：製品推定・動向分析

  • 医療用サイクロトロン市場：重要なポイント
  • 医療用サイクロトロン市場：動向と市場シェア分析、2022年と2030年
  • サイクロトロン10-12MeV
  • サイクロトロン16-18MeV
  • サイクロトロン19-24MeV
  • サイクロトロン24MeV超

第5章 医療用サイクロトロン市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別の医療用サイクロトロン市場：主要マーケットプレースの要点
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Siemens Medical Solutions USA, Inc
    • IBA Radiopharma Solutions
    • GE HealthCare
    • Advanced Cyclotron Systems, Inc
    • TeamBest
    • Sumitomo Heavy Industries, Ltd
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 3 North America Medical Cyclotron Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 U.S. Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Canada Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 6 Europe Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 7 Europe Medical Cyclotron Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 Germany Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 9 UK Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 France Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 Italy Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 12 Spain Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 Sweden Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Norway Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 Denmark Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Medical Cyclotron Market, by Region, 2018 - 2030 (USD Million)
  • Table 18 China Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Japan Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 India Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Thailand Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 South Korea Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Latin America Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Latin America Medical Cyclotron Market, by Region, 2018 - 2030 (USD Million)
  • Table 25 Brazil Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Argentina Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 Middle East and Africa Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa Medical Cyclotron Market, by Region, 2018 - 2030 (USD Million)
  • Table 30 South Africa Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 Saudi Arabia Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 UAE Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Kuwait Medical Cyclotron Market, by Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Medical cyclotron: Market outlook
  • Fig. 9 Medical cyclotron : Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Medical cyclotron market driver impact
  • Fig. 15 Medical cyclotron market restraint impact
  • Fig. 16 Medical cyclotron market strategic initiatives analysis
  • Fig. 17 Medical cyclotron market: Product movement analysis
  • Fig. 18 Medical cyclotron market: Product outlook and key takeaways
  • Fig. 19 Cyclotron 10-12MeV market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cyclotron 16-18MeV market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Cyclotron 19-24MeV market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Cyclotron above 24MeV market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global Medical cyclotron market: Regional movement analysis
  • Fig. 24 Global Medical cyclotron market: Regional outlook and key takeaways
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-159-7

Medical Cyclotron Market Growth & Trends:

The global medical cyclotron market size is expected to reach USD 477.9 million by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 11.0% during the forecast period. Increasing prevalence of cancer and surging demand for nuclear scans for accurate diagnosis are among the key factors stimulating the growth of the market. Apart from this, cost advantage over outsourced radioactive tracers and availability of technologically advanced diagnostic devices such as PET and SPECT are playing a pivotal role to escalate market growth.

Cancer is becoming the global pandemic as it causes one in eight deaths worldwide. According to the International Agency for Research on Cancer (IARC), in 2012, there were about 14.1 million new cancer cases and 8.2 million deaths due to cancer. With continuous increase in the incidence of chronic diseases, the number of new cancer cases is anticipated to reach 21.7 million and result in 13 million deaths by 2030. Due to mounting cases of cancer, the need for accurate diagnostics is increasing, which is estimated to fuel the demand for medical cyclotrons.

Nuclear scans for diagnosis use a smaller amount of radioactive material. Nuclear tracers help to find the exact location of growing tumors. Technetium-99m (Tc-99m), strontium, thallium, gallium, and radioactive iodine are some of the radioactive materials used in diagnosis and treatment of tumor. Increase in acceptability of particle accelerators for manufacturing tracer material is projected to trigger the growth of the market over the forecast period.

Medical Cyclotron Market Report Highlights:

  • Asia Pacific held the leading share of about 50.0% in 2022, due to spiraling demand for nuclear scans, rising cancer prevalence, and increasing demand for cost-effective diagnosis.
  • Middle East & Africa is expected to grow at the fastest CAGR of 16.7% during the forecast period.
  • The cyclotron 19-24 MeV segment is expected to grow at the fastest CAGR of 12.1 % over the forecast period of 2023 - 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Cyclotron Market, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Medical Cyclotron Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Medical Cyclotron Market: Product Estimates & Trend Analysis

  • 4.1. Medical Cyclotron Market: Key Takeaways
  • 4.2. Medical Cyclotron Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cyclotron 10-12MeV
    • 4.3.1. Cyclotron 10-12MeV market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Cyclotron 16-18MeV
    • 4.4.1. Cyclotron 16-18MeV market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Cyclotron 19-24MeV
    • 4.5.1. Cyclotron 19-24MeV market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Cyclotron above 24MeV
    • 4.6.1. Cyclotron above 24MeV market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Medical Cyclotron Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Medical Cyclotron Market by Region: Key Marketplace Takeaway
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Siemens Medical Solutions USA, Inc
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. IBA Radiopharma Solutions
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. GE HealthCare
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Advanced Cyclotron Systems, Inc
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. TeamBest
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Sumitomo Heavy Industries, Ltd
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives